Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

# AGENCY:

Assistant Secretary for Planning and Evaluation, HHS.

# ACTION:

Notice of meeting.

# SUMMARY:

This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and Services (Advisory Council). The Advisory Council provides advice on how to prevent or reduce the burden of Alzheimer's disease and related dementias on people with the disease and their caregivers. During the meeting, the Advisory Council will hear updates from federal agencies on activities during the last quarter and from panels organized by the clinical care and risk reduction subcommittees. Presenters will discuss dementia care from different perspectives, including those of providers, people with lived experience, and CMMI GUIDE Model participants, as well as how to bridge gaps in service delivery.

# DATES:

The meeting will be October 21, 2024, from 9:30 a.m. to 4:30 p.m.

# ADDRESSES:

                        The meeting will be a hybrid of in-person and virtual. The meeting will be held in Room 800 of the Hubert H. Humphrey Building, 200 Independence Avenue SW, Washington, DC 20201. It will also stream live at                         *www.hhs.gov/​live*.                    

*Comments:*                         Time is allocated on the agenda to hear public comments from 4:00 p.m. to 4:25 p.m. on Monday, October 21. The time for oral comments will be limited to two (2) minutes per individual. To provide a public comment, please register by emailing your name to                         *napa@hhs.gov*                         by Wednesday, October 16. Registered commenters will receive both a dial-in number and a link to join the meeting virtually; individuals will have the choice to either join virtually via the link, or to call in only by using the dial-in number.                         *Note:*                         There may be a 30-45 second delay in the livestream video presentation of the conference. For this reason, if you have pre-registered to submit a public comment, it is important to connect to the meeting by 3:45 p.m. to ensure that you do not miss your name and allotted time when called. If you miss your name and allotted time to speak, you may not be able to make your public comment. Public commenters will not be admitted to the virtual meeting before 3:30 p.m. but are encouraged to watch the meeting at                         *www.hhs.gov/​live.*                         Should you have questions during the session, please email                         *napa@hhs.gov*                         and someone will respond to your message as quickly as possible.                    

                        To ensure accuracy, please submit a written copy of oral comments for the record by emailing                         *napa@hhs.gov*                         by Wednesday, October 23, 2024. These comments will be shared on the website and reflected in the meeting minutes.                    

                        In lieu of oral comments, formal written comments may be submitted for the record by Wednesday, October 23, 2024, to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to                         *napa@hhs.gov.*                         Those submitting written comments should identify themselves and any relevant organizational affiliations.                    

# FOR FURTHER INFORMATION CONTACT:

                        Helen Lamont, 202-260-6075,                         *helen.lamont@hhs.gov.**Note:*                         The meeting will be available to the public live at                         *www.hhs.gov/​live*.                    

# SUPPLEMENTARY INFORMATION:

Notice of these meetings is given under the Federal Advisory Committee Act(5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: Alzheimer's disease-related dementias, clinical care, risk reduction.

*Procedure and Agenda:*                     The meeting will be webcast at                     *www.hhs.gov/​live*                     and video recordings will be added to the National Alzheimer's Project Act website when available after the meeting. This meeting is open to the public. Please allow 30 minutes to go through security and walk to the meeting room. Participants joining in person should note that seating may be limited. Those wishing to attend the meeting in person must send an email to                     *napa@hhs.gov*                     and put “October 21 Meeting Attendance” in the subject line by Wednesday, October 16 so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email.                

*Authority:*42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer's Project Act. The panel is governed by provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees.                

Dated: September 17, 2024.

Tisamarie B. Sherry,

Deputy Assistant Secretary for Behavioral Health, Disability, and Aging Policy, performing the delegable duties of the Assistant Secretary for Planning and Evaluation.

[FR Doc. 2024-22763 Filed 10-2-24; 8:45 am]

BILLING CODE 4150-05-P